The GR plays a complex role in PCa: in the presence of active AR signaling, glucocorticoids have antitumor effects; however, androgen deprivation increases GR expression, which allows GR to transcriptionally express AR target genes and GR target genes, contributing to tumor resistance to anti-androgen therapy. Here, NR3C1 is linked to neoplasm.